Articles Mentioning Pharmaceuticals Stocks

Results 1 - 10 of 968 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals

Investing | June 21, 2016

7 Pharmaceutical Stocks With Dividends Yielding More Than 3%

Drug companies tend to offer investors some of the highest dividend yields from the healthcare sector. But only two of seven pharmaceutical stocks currently yielding more than 3% are worth buying.

Investing | June 15, 2016

Better Buy: Johnson & Johnson vs. Eli Lilly

It's a showdown between the healthcare conglomerate and the diabetes pioneer.

Investing | June 11, 2016

George Soros' Worst-Performing Stocks of 2016 So Far

A collection of underperforming stocks held by Soros Fund Management that could be set to bounce strongly.

Investing | June 09, 2016

3 Reasons Why Cempra, Inc. Rallied 10.99% in May

Here's a look at the reasons why shares of Cempra jumped last month.

Investing | June 06, 2016

What AbbVie Bought for $5.8 Billion

The murky acquisition of Stemcentryx and its lung cancer candidate, Rova-T, just became a much clearer.

Investing | June 04, 2016

Is AbbVie's Stock Too Risky?

AbbVie's risk profile has ballooned over the past year. Here's why.

Investing | May 25, 2016

Billionaires Are Bailing on Gilead Sciences -- Should You, Too?

Slowing sales growth for the company's hepatitis C drugs may have some Wall Street money managers cautious, but with the company's shares on sale, everyday investors may find that there's value in buying this beaten-up biotech.

Investing | May 21, 2016

Here's What Pfizer's Telling Us About Biotech M&A

Pfizer's acquisition of Anacor shows M&A is alive and well for biotech companies with late-stage research programs.

Investing | May 12, 2016

3 Risky Biotechs With FDA Decisions On Deck -- Are They Buys?

Sarepta Therapeutics, Synergy Pharmaceuticals, and Celator Pharmaceuticals all hope to have drugs on the market soon.

Investing | April 13, 2016

AbbVie's Venclexta Notches FDA Win, But Investors Might Want To Temper Enthusiasm

Venclexta's approval in CLL is important, but another drug making its way to market could reduce its use someday.

Results 1 - 10 of 968 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals